8-K: Functional Brands Q3 2025: Revenue Up 21.4%, Nasdaq Listing

Functional Brands Inc. reports strong third-quarter 2025 financial results with significant revenue growth and a successful Nasdaq direct listing.

Summary

• Revenue for the third fiscal quarter ended September 30, 2025, was $1.7 million, an increase of 21.4% compared to the third quarter of 2024, primarily driven by growth in direct-to-consumer sales.
• Gross profit increased 28.1% compared to the prior year period, and gross profit margin improved 310 basis points to 57.8%, reflecting higher revenue, improved cost control, and better vendor terms.
• The company achieved a net income of $0.3 million, or $0.04 per diluted share, for Q3 2025, a significant improvement from a net loss of $0.3 million, or $(0.04) per diluted share, in Q3 2024.
• Functional Brands Inc. successfully completed its direct listing on the Nasdaq Capital Market under the symbol MEHA.
• The P2i by Kirkman prenatal supplement became the world's first to fully align with FIGO's transparency standards and the first to comply with California's new SB 646 QR-code disclosure law, well ahead of the January 2027 implementation date.
• A high-impact commercial partnership was forged with Market Performance Group to accelerate the growth of the flagship Kirkman brand across eCommerce and digital channels.

Sentiment

Score: 8

Explanation: The company reported strong Q3 financial results with significant revenue growth and a shift from net loss to net income. Key strategic milestones, including a Nasdaq direct listing, pioneering product compliance, and a major commercial partnership, indicate strong positive momentum and future growth potential.

Positives

• Revenue increased 21.4% to $1.7 million in Q3 2025 compared to Q3 2024.
• Gross profit increased 28.1% year-over-year, and gross profit margin improved 310 basis points to 57.8%.
• Achieved a net income of $0.3 million ($0.04 per diluted share) in Q3 2025, a significant turnaround from a net loss of $0.3 million ($(0.04) per diluted share) in the prior year period.
• Successfully completed a direct listing on the Nasdaq Capital Market under the symbol MEHA, providing a capital foundation for expansion.
• The P2i by Kirkman prenatal supplement achieved world-first compliance with FIGO transparency standards and California's SB 646 QR-code disclosure law, demonstrating leadership in product transparency and regulatory readiness.
• Established a high-impact commercial partnership with Market Performance Group to boost the Kirkman brand's growth in e-commerce and digital channels.
• Cash balance increased significantly to $1,005,324 as of September 30, 2025, from $211,642 as of December 31, 2024.
• Total stockholders' equity turned positive to $604,665 as of September 30, 2025, from a deficit of $(118,577) as of December 31, 2024.

Negatives

• Interest expense significantly increased to $155,310 in Q3 2025 from $69,638 in Q3 2024.
• General and administrative expenses increased to $937,762 in Q3 2025 from $825,993 in Q3 2024.
• The company reported an operating loss of $(78,288) for Q3 2025 and a net loss of $(93,837) for the nine months ended September 30, 2025.

Risks

• Forward-looking statements are subject to significant known and unknown risks, uncertainties, and other factors which may be beyond the company's control.
• Potential investors are advised to review Functional Brands' Registration Statement for more complete information, including the risk factors that may affect future results, which are available at www.sec.gov.

Future Outlook

The company is positioned strongly for accelerated growth, aiming for sustainable, profitable growth, and unlocking new opportunities to reach millions of consumers with its science-based wellness solutions. Management believes these accomplishments demonstrate execution on their mission while building a foundation for future growth.

Management Comments

• "We are pleased with our third quarter results as we delivered strong growth on the top and bottom line, reflecting early progress on our key initiatives."
• "The past few months have been transformational for Functional Brands, marked by several milestone achievements that position us strongly for accelerated growth."
• "These accomplishments demonstrate that we are executing on our mission of Making Everyone Healthy Again while building a foundation for sustainable, profitable growth."

Industry Context

Functional Brands operates in the health and wellness sector, focusing on acquiring and growing science-based consumer brands. The company's strategic moves, such as the Nasdaq listing and partnership with Market Performance Group, align with broader industry trends towards enhanced market access through e-commerce and digital channels. Its pioneering compliance with FIGO standards and California's SB 646 positions it as a leader in transparency and regulatory adherence within the specialized prenatal supplement market, potentially setting new benchmarks for competitors.

Comparison to Industry Standards

• The P2i by Kirkman prenatal supplement is the world's first to fully align with FIGO's transparency standards, setting a global benchmark for product disclosure in the prenatal category.
• P2i by Kirkman is also the first to comply with California's new SB 646 QR-code disclosure law, well ahead of its January 2027 implementation date, demonstrating proactive regulatory leadership compared to industry peers.
• The commercial partnership with Market Performance Group to supercharge growth across eCommerce and digital channels is a common strategy for consumer brands seeking to expand market share and reach in the evolving digital retail landscape.

Corporate Governance

Related Party Transactions

• Loans payable (related party), current: $58,886 as of September 30, 2025, down from $370,703 as of December 31, 2024.
• Loans payable (related party), net of current: $260,992 as of September 30, 2025, compared to $0 as of December 31, 2024.
• Non-cash financing activity included a loan payable, related party, of $225,000 for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, successful Nasdaq listing, and strategic initiatives aimed at accelerated growth and profitability. The shift from a net loss to net income and positive stockholders' equity is beneficial.
• Customers: Enhanced access to products through expanded e-commerce and digital channels, and assurance of high-quality, compliant products like P2i by Kirkman, which meets leading transparency standards.
• Employees: Potential for growth and stability within the company due to strategic expansion and improved financial health.
• Vendors: Improved cost control and better terms with vendors were mentioned as factors contributing to gross profit margin improvement.

Next Steps

• Execute ambitious expansion plans following the Nasdaq direct listing.
• Continue to supercharge the growth of the flagship Kirkman brand across eCommerce and digital channels.
• Continue building a foundation for sustainable, profitable growth.

Key Dates

Recommendation

The company demonstrated a significant turnaround in Q3 2025, moving from a net loss to a net income with substantial revenue and gross profit growth. The successful Nasdaq direct listing provides a strong capital foundation for future expansion. Strategic achievements, such as the pioneering compliance of P2i by Kirkman and the partnership with Market Performance Group, position Functional Brands for accelerated and sustainable growth in the health and wellness market. These factors collectively indicate strong positive momentum and future value creation, making it an attractive investment.

Keywords

Functional Brands, MEHA, Nasdaq, Financial Results, Q3 2025, Wellness Products, Kirkman, P2i, Direct-to-consumer, Gross Profit, Net Income, SEC Filing, Consumer Brands, Health